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Pluripotent stem cell-derived cardiomyocytes (CMs) have great potential in the development of new therapies for 
cardiovascular disease. In particular, human induced pluripotent stem cells (iPSCs) may prove especially advanta-
geous due to their pluripotency, their self-renewal potential, and their ability to create patient-speciﬁc cell lines. 
Unfortunately, pluripotent stem cell-derived CMs are immature, with characteristics more closely resembling fetal 
CMs than adult CMs, and this immaturity has limited their use in drug screening and cell-based therapies. Extra-
cellular matrix (ECM) inﬂuences cellular behavior and maturation, as does the geometry of the environment—two-
dimensional (2D) versus three-dimensional (3D). We therefore tested the hypothesis that native cardiac ECM and 
3D cultures might enhance the maturation of iPSC-derived CMs in vitro. We demonstrate that maturation of iPSC-
derived CMs was enhanced when cells were seeded into a 3D cardiac ECM scaffold, compared with 2D culture. 3D 
cardiac ECM promoted increased expression of calcium-handling genes, Junctin, CaV1.2, NCX1, HCN4, SERCA2a, 
Triadin, and CASQ2. Consistent with this, we ﬁnd that iPSC-derived CMs in 3D adult cardiac ECM show increased 
calcium signaling (amplitude) and kinetics (maximum upstroke and downstroke) compared with cells in 2D. Cells in 
3D culture were also more responsive to caffeine, likely reﬂecting an increased availability of calcium in the 
sarcoplasmic reticulum. Taken together, these studies provide novel strategies for maturing iPSC-derived CMs that 
may have applications in drug screening and transplantation therapies to treat heart disease. 
Introduction 
Cardiovascular disease is the number one cause of death in the United States and most of the developed 
world. It most commonly manifests as a myocardial in-
farction, an ischemic event in the heart that results in the 
death of millions to billions of cardiomyocytes (CMs). The 
loss of CMs can impair heart function, and repair is limited 
due to the extremely low proliferation rate of endogenous 
CMs. Compounding the insult, damaged tissue undergoes 
ﬁbrosis, which increases the risk of arrhythmia and subse-
quent heart failure. There is no available drug treatment that 
can regenerate the lost myocardium, resulting in a critical 
need to ﬁnd new treatment strategies. 
Recent studies have focused on the potential regenerative 
capacity of exogenous CMs as a novel treatment following 
myocardial infarction and, in particular, on the derivation of 
these from induced pluripotent stem cells (iPSCs) generated 
from the patient’s own cells. Several studies report trans-
plantation of human embryonic stem cell (hESC) and iPSC-
derived CMs into ischemic hearts, largely in mouse and rat, 
where improvements in heart function have been observed.1–8 
A limitation to this approach is that pluripotent stem cell-
derived CMs generated through current methods are im-
mature, displaying characteristics of fetal CMs. Speciﬁcally, 
the cells show disorganized sarcomere structures, weak 
force contraction, automaticity (spontaneous beating), im-
proper calcium handling and electrophysiological signaling, 
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low expression of critical cardiac proteins, and altered re-
sponses to drugs when compared with mature CMs.9 Not 
surprisingly then, there is growing evidence that mature CMs 
outperform immature CMs for tissue replacement strategies 
and screening of novel pharmacologic compounds—they 
produce stronger force contraction and show appropriate 
calcium handling and electrophysiology.10–12 In addition, 
the loss of automaticity seen in mature CMs (which require 
pacemaker cells to trigger beating) will greatly improve 
safety by eliminating potential arrhythmic events. Last, the 
use of mature CMs for drug screening has clear advantages 
over the use of immature cells for predicting efﬁcacy and 
potential side effects.13 It is clear therefore that strategies are 
needed that promote more efﬁcient generation of mature CMs 
from iPSCs. 
Several methods have been developed to induce matura-
tion of pluripotent stem cell derived-CMs, including exposure 
to triiodothyronine (T3 thyroid hormone),11 exposure to non-
CM cells,14 mechanical stress,15 or microRNA,16 as well as 
overexpression of potassium channels17 and long-term cul-
ture.10 In addition, there is also evidence that extracellular 
matrix (ECM) can affect both cell and organ maturation.18–25 
Importantly, two-dimensional (2D) culturing on porcine car-
diac ECM affects rat and human CM development and 
maturation,26–28 and cardiac ECM can have therapeutic ef-
fects when injected into the heart after a myocardial infarc-
tion.29 Studies have shown that fetal and adult cardiac ECMs 
have different effects on rat neonatal CM proliferation30; 
however, whether this is true for human iPSC-derived CMs is 
not known. It is also unclear how a 2D versus a three-
dimensional (3D) growth environment might inﬂuence CM 
maturation or whether matrix from fetal versus adult heart 
might make a difference. In this study, we compare the ef-
fects of 2D versus 3D and fetal versus adult matrix on the 
maturation of iPSC-derived CMs, and ﬁnd that both source 
and geometry of the matrix are important. 
Materials and Methods 
iPSC maintenance and cardiac differentiation 
All experiments were performed with approval from UC 
Irvine’s Human Stem Cell Research Oversight Committee 
and used the human WTC-11 GCaMP iPSC line, which was a 
gift from Dr. Bruce Conklin (UCSF).31 The WTC-11 iPSC 
line was derived from a healthy male volunteer with a nor-
mal electrocardiogram and no known family history of car-
diac disease. The GCaMP iPSC line was generated using 
nuclease-mediated (TALEN) introduction of GCaMP6f,32 
and the resulting cell line reports calcium ﬂuxes through GFP 
ﬂuorescence. The iPSCs were maintained on Growth Factor-
Reduced Matrigel (Corning, Salt Lake City, UT) and fed 
daily with mTeSR1 medium (StemCell Technologies, Van-
couver, Canada). To induce CM differentiation, iPSCs were 
seeded as single cells into 12-well plates coated with 1 mg 
Matrigel Growth Factor Reduced (#354230; BD) in the 
presence of 10 mM Y-27632 (Ascent, Cambridge, MA). 
Cardiac induction was initiated 2–4 days later (designated as 
Day 0), when cells were 75–90% conﬂuent by the addition of 
glycogen synthase kinase 3 inhibitor (CHIR99021, 6 mM; 
Tocris, Inc., Bristol, United Kingdom) in RPMI/B27 (without 
insulin; Life Technologies, Carlsbad, CA).33 Twenty-four 
hours later (Day 1), the medium was changed to fresh RPMI/ 
B27 (without insulin). On Day 3, Wnt inhibitor (IWP2, 5 mM; 
Tocris) was added in RPMI/B27 (without insulin), and at Day 
5, cells were fed fresh RPMI/B27 (without insulin). The cells 
were subsequently fed RPMI/B27 (with insulin) (Life Tech-
nologies) every 3 days starting at Day 7. Cells began to 
spontaneously beat by Day 12. 
Cardiac tissue decellularization and ECM generation 
Bovine adult and fetal hearts were purchased from Sierra 
Medical. Before decellularization, the tissue (100–200 g) 
was processed by removing all excess fat and stored at 
-80 C for at least 16 h. Next, the tissue was cut into 3 mm3-
sized pieces and subjected to continuous stirring at 330 
RPM during incubation in the following solutions at room 
temperature: ddH20 for 30 min, 2· phosphate-buffered sa-
line (PBS) for 15 min, sodium dodecyl sulfate (SDS) (1% 
for adult tissue and 0.5% for fetal tissue; Bio-Rad) for 72 h, 
and 1% Triton for 90 min. This was followed by seven 
washes in ddH20 for 30 min each, and 18 h in PBS with 
antibiotic–antimycotic (Life Technologies) at 4 C. 
Decellularized tissues were lyophilized and then milled 
using a cheese grater (Amazon.com, Seattle, WA) to create a 
ﬁne powder. The ECM powder was digested with 2 mg/mL 
pepsin (Sigma-Aldrich, St. Louis, MO) diluted in 0.01 M cell 
culture grade hydrochloric acid (HCl). Approximately 200 mg 
of cardiac ECM was added to 20 mg of pepsin and continu-
ously stirred at 330 RPM at room temperature for 48–72 h or 
until fully digested. The digested ECM was divided into 1 mL 
aliquots and stored at -80 C until needed. 
Multiphoton imaging and ﬁber analysis 
Fibrillar collagen can be identiﬁed by second-harmonic 
generation (SHG) signals when incident light interacts with 
its noncentrosymmetric structure, and SHG microscopy has 
been widely used to study collagen ﬁbers in vivo and 
34–36 in vitro. In addition, elastin ﬁbers are autoﬂuorescent due 
to elastin’s tricarboxilic, triamino pyridinium derivatives, and 
are therefore visualized using multiphoton microscopy.37 
Imaging was performed in the Laboratory for Fluores-
cence Dynamics (LFD) at UCI.38 A Ti:Sapphire laser (Mai 
Tai; Spectra Physics, Irvine, CA) was used for two-photon 
ﬂuorescence excitation with a wavelength of 740 nm (SHG) 
and 860 nm (autoﬂuorescence) with an incident power of 
20 mW. The signal was collected using a water objective 
with a long working distance (LUMPlanFl 40 · /0.80 W; 
Olympus, Tokyo, Japan). The SHG signal was obtained 
using a 320–390 nm bandpass ﬁlter. The autoﬂuorescent 
signal was collected using a 500 nm long-pass ﬁlter. Images 
were captured every 5 mm through the 3D scaffolds with a 
ﬁeld of view of 8464 mm2. Data acquisition was performed 
in SimFCS (software developed by the LFD). The images 
were analyzed using ctFIRE MATLAB (http://loci.wisc.edu/ 
software/ctﬁre) by extracting information corresponding to 
the ﬁber width and number. The data were collected from 
three separate z-stacks for each sample. 
Statistical analysis 
Split-Unit ANOVA was used to analyze quantitative re-
verse transcription polymerase chain reaction (qRT-PCR) 
data using R analysis (d p > 0.05, dd p > 0.01). Figures show the 
standard error of the mean with n = 3 unless otherwise stated. 
Student’s t-test was performed on GCaMP calcium transients 
and standard error of the mean is shown (***p < 0.001, 
**p < 0.01, *p < 0.05). 
Additional information and explanation of methods can 
be found in the Supplementary Data (Supplementary Data 
are available online at www.liebertpub.com/tea). 
Results 
Characterization of ECM from decellularized adult 
and fetal bovine cardiac tissue 
To investigate the potential differences between fetal and 
adult cardiac ECMs and their respective contributions to 
human iPSC-derived CM maturation, we isolated cardiac 
ECM through SDS- and Triton-X100 detergent-mediated 
decellularization of fetal and adult bovine heart muscle. We 
found that similar polymerization characteristics could be 
obtained using 1% SDS for the adult tissue and 0.5% SDS 
for the fetal tissue (Supplementary Table S1). Importantly, 
the fetal cardiac ECM decellularized with either 0.5% or 1% 
SDS induced a similar gene expression proﬁle compared 
with adult cardiac ECM when used in 2D assays (Supple-
mentary Fig. S1). H&E staining conﬁrmed the removal of 
cells during the decellularization process (Fig. 1A–D). 
The protein compositions of fetal and adult cardiac ECMs 
were characterized by nano-LC MS/MS. At the score 
S2),55–57thresholds employed (Supplementary Table the 
prominent proteins were ﬁbrinogen, collagen, periostin, ﬁ-
brillin, ﬁbulin, ﬁbronectin, and other matrix proteins (Sup-
plementary Table S2). The fetal cardiac ECM samples 
contained two unique proteins not found in the adult sam-
ples, mimecan and versican (Supplementary Table S2). To 
examine the structure and distribution of collagen and 
elastin within the ECM, we used SHG to detect collagen 
ﬁbers and autoﬂuorescence to detect elastin ﬁbers. The 
elastin ﬁbers of the fetal ECM, before pepsin digestion, were 
more evenly distributed, while there were more deﬁned 
organized bundles in the adult ECM (Fig. 1E, F). In contrast 
to fetal ECM, the decellularized adult cardiac ECM dis-
played a higher collagen ﬁber signal intensity and larger 
bundles evident by increased ﬁber width and number 
(Fig. 1G–J). Hydrogels were formed with the adult and fetal 
cardiac ECMs, and storage modulus (G¢) and loss modulus 
(G†) were measured by parallel plate rheology. The adult 
cardiac ECM (67.5 – 12.6 Pa) was *10-fold stiffer than 
fetal cardiac ECM (7.2 – 3.2 Pa) (Table 1 and Supplemen-
tary Fig. S2). 
3D adult cardiac ECM promotes expression 
of CM maturation genes 
To determine if cardiac ECM affects iPSC-derived CM 
maturation, we examined gene expression (by qRT-PCR) in 
cells cultured in 2D and 3D fetal and adult cardiac ECMs 
(Supplementary Table S4). After 7 days in culture, iPSC-
derived CMs seeded into 3D cardiac ECM (from fetal or 
adult tissue) expressed higher levels of numerous 
maturation-related genes compared with cells in 2D gels. 
These included genes related to calcium handling, such as 
Junctin ( JCN), L-type voltage-dependent calcium channel 
FIG. 1. Characterization of cardiac ECM from decel-
lularized bovine fetal and adult heart tissue. Decellularized 
adult bovine cardiac tissue has a more prominent ﬁbrillar 
structure than fetal cardiac tissue. (A, C, E, and G) Fetal 
heart tissue. (B, D, F, and H) Adult heart tissue. (A, B) 
Control tissue. (C–H) Decellularized tissue. (E, F) Elastin 
ﬁbers visualized by autoﬂuorescence at 860 nm. (G, H) 
Collagen ﬁbers visualized by second-harmonic generation at 
740 nm. (I) Quantiﬁcation of the number of collagen ﬁbers 
comparing fetal and adult decellularized cardiac tissue. (J)  
Collagen ﬁber width comparing fetal and adult decellular-
ized cardiac tissue. Results are expressed as mean – standard 
error (n = 3; *p < 0.05, **p < 0.01, Student’s t-test). ‘‘#’’ re-
fers to number of collagen ﬁbers per ﬁeld of view (FOV). 
ECM, extracellular matrix. Color images available online at 
www.liebertpub.com/tea 
Table 1. Mechanical Properties of Fetal 







Fetal (n = 3) 
Adult (n = 3) 
7.2 – 3.2 
67.5 – 12.6 
1.3 – 0.58 
26.2 – 14.1 
Parallel plate rheology was used to determine storage and loss 
moduli at an oscillation rate of 1 Hz with a 1% strain amplitude. 
Results are expressed as mean – standard error. 
ECM, extracellular matrix. 
(CACNA1C/CaV1.2), calsequestrin 2 (CASQ2), and sodi-
um–calcium exchanger 1 (NCX1), which were augmented 
between 2- and 120-fold (Fig. 2A, B and Supplementary 
Table S3). We also saw similar increases in expression of 
several other genes related to cardiac maturation, including 
inward rectiﬁer potassium ion channel (KCNJ2/Kir2.1), 
Triadin, sarcoplasmic reticulum (SR) Ca2+ ATPase (SERCA2a), 
and potassium/sodium hyperpolarization-activated cyclic 
nucleotide-gated channel 4 (HCN4) in 3D versus 2D cul-
ture (Supplementary Fig. S3). In addition, we also noted 
strong induction of these same genes, such as JCN, when  
comparing adult with fetal matrix, with the augmentation 
being particularly marked in 3D cultures (Fig. 2C, D). We 
next examined the expression of key structural and calcium-
handling genes at the protein level. After 21 days of cardiac 
induction, 50–90% of differentiated cells expressed cardiac 
troponin T (cTNT), which is a marker of CM differentiation 
(Fig. 3A). Conﬁrming our qRT-PCR data, we found a strong 
induction of CaV1.2, MYL2, and connexin 43 (Cx43) pro-
tein in iPSC-derived CMs cultured in 3D adult cardiac 
ECM, compared with 2D (Fig. 3B and Supplementary 
Fig. S4). In addition, the iPSC-derived CMs cultured on 
adult cardiac ECM exhibited increased expression of MYL2 
compared with cells on fetal ECM (Supplementary Fig. S5). 
Thus, both the source (fetal vs. adult) and the geometry (2D 
vs. 3D) of ECM strongly inﬂuence maturation of iPSC-
derived CMs. 
Cardiac ECM geometry affects iPSC-derived 
CM calcium signaling 
The genetically encoded ﬂuorescent calcium ﬂux reporter 
GCaMP631 was utilized to assess the functional effects of 
ECM geometry on iPSC-derived CM calcium handling. We 
ﬁrst compared single cells in 2D culture with single cells 
embedded in 3D gels. When cultured for 7 days in 3D 
cardiac ECM, the iPSC-derived CMs showed a signiﬁcant 
FIG. 2. 3D adult cardiac ECM 
increases iPSC-derived CM ex-
pression of structural and func-
tional cardiac genes. Gene 
expression was measured using 
qRT-PCR and expression normal-
ized to 2D fetal cardiac ECM. 
Cardiac genes measured were JCN, 
CACNA1C/CaV1.2, Cx43, CASQ2, 
NCX1, and MYL2. (A) Gene ex-
pression in iPSC-derived CMs 
cultured in (3D) or on (2D) fetal 
cardiac ECM (*p > 0.01, 
**p > 0.001, Student’s t-test). 
(B) Gene expression in iPSC-
derived CMs cultured in (3D) or on 
(2D) adult cardiac ECM. (C, D) 
Data from (A, B) replotted to aid 
direct comparison of gene expres-
sion in iPSC-derived CMs cultured 
on adult and fetal 2D cardiac 
ECMs (C) and 3D cardiac ECM 
(D). Unless otherwise indicated, 
results are expressed as 
mean – standard error. (n = 3;
d p > 0.05, dd p > 0.01, Split-Unit 
ANOVA). 2D, two-dimensional; 
3D, three-dimensional; CACNA1C/ 
CaV1.2, L-type voltage-dependent 
calcium channel; CASQ2, calse-
questrin 2; Cx43/GJA1, connexin-
43; iPSC, induced pluripotent stem 
cell; JCN, junctin; MYL2, myosin 
light chain 2; NCX1, sodium–cal-
cium exchanger 1; qRT-PCR, 
quantitative reverse transcription 
polymerase chain reaction. 
FIG. 3. 3D adult cardiac ECM 
increases iPSC-derived CM protein 
expression of structural and 
calcium-handling proteins. iPSC-
derived CMs express sarcomere 
and calcium-handling proteins. 
(A) Flow cytometry analysis for 
cTNT(+) cells after 21 days of 
differentiation. (B) Immuno-
ﬂuorescent staining for MYL2 and 
CaV1.2 in iPSC-derived CMs cul-
tured in 2D and 3D cardiac ECMs. 
(Right panels) MYL2 staining. 
(Left panels) CaV1.2 staining. 
Scale bar is 50 mm. Color images 
available online at www.liebertpub 
.com/tea 
decrease in beat rate compared with 2D culture (Fig. 4A). 
Interestingly, we also saw a decrease in calcium transient 
amplitude, maximum upslope, and maximum downslope 
and a concomitant increase in time to 50% decay (Fig. 4B–E). 
These data demonstrate a clear effect of matrix geometry on 
CM calcium handling. In vivo CMs are in close association 
and the formation of syncytia promotes electrical coupling. 
To mimic this, we cultured aggregates of iPSC-derived CMs 
in 3D gels and also allowed these to settle onto 2D gels. 
Perhaps, not surprisingly, we found the calcium-handling 
capabilities of the cells under these conditions to be quite 
different from those seen when the cells are not in close 
association. Representative traces of calcium inﬂux are 
shown in Figure 4F. Calcium transient amplitude, maximum 
upslope, and maximum downslope were all increased (they 
were decreased with single cells) and the time to peak, time 
to 50% decay, and time to 75% decay were correspondingly 
decreased when cells were in 3D versus 2D (Fig. 4G–J and 
Supplementary Fig. S6A–E). Beat rate was not signiﬁcantly 
altered by matrix geometry (data not shown). We also ex-
amined iPSC-derived CM behavior in a third model—cardiac 
spheroids embedded in 3D hydrogels comprising adult por-
cine cardiac ECM, ﬁbrin, or collagen I. Compared with either 
ﬁbrin or collagen I, cells in native cardiac matrix showed a 
decreased beat rate (Supplementary Fig. S7). These data are 
consistent with the promotion of CM maturation by native 
heart matrix. 
3D adult cardiac ECM increases iPSC-derived 
CM response to drugs 
To further assess the functionality of iPSC-derived CMs in 
3D cardiac ECM, cells were exposed to isoproterenol and 
propranolol, drugs known to modulate b-adrenergic signaling 
and consequently calcium handling. Consistent with the 
known behavior of adult CMs, the iPSC-derived CMs in-
creased their beat rate upon the addition of 1 mM isoproter-
enol (Fig. 5A) and this was decreased to baseline levels 
following the addition of 10 mM propranolol (Fig. 5A). Caf-
feine targets the ryanodine receptor (RyR), resulting in an 
increase in available calcium. Exposure of iPSC-derived CMs 
to caffeine resulted in a more rapid release of calcium in 3D 
FIG. 4. 3D adult cardiac ECM increases calcium signaling in iPSC-derived CMs. A GCaMP reporter was used to visualize calcium 
transients in iPSC-derived CMs after 7 days in 2D and 3D adult cardiac ECMs. (A–E) iPSC-derived CMs cultured in 3D as single cells 
displayed decreased calcium signaling and kinetics. (F–J) iPSC-derived CMs cultured in 3D as aggregates displayed an increase in 
calcium signaling and kinetics compared with 2D. (A) Beat rate of iPSC-derived CMs cultured in 2D and 3D adult/fetal cardiac 
ECMs. (B, G) Amplitude. (C, H) Max Upslope. (D, I) Max Downslope. (E, J) Time to 50% decay. (F) Representative calcium wave 
transient of iPSC-derived CM culture in 2D and 3D adult cardiac ECMs. Results are expressed as mean – standard error (n = 4–12; 
*p < 0.05, **p < 0.01, ***p < 0.001, Student’s t-test). 
culture than in 2D (Fig. 5B). The upslope was steeper and 
the time to maximum calcium concentration was quicker 
(Fig. 5C, D). Thus, iPSC-derived CMs are responsive to 
drugs with known cardiac effects and these effects are 
more pronounced in 3D versus 2D culture. 
Discussion 
Myocardial infarction results in the death of millions to 
billions of CMs, and the lack of endogenous CM regeneration 
within the heart means that these cells are not replaced. A 
potential strategy to help these patients is to transplant CMs 
grown outside of the body, which will require establishment 
of procedures for the generation of large quantities of mature, 
or close to mature, CMs. iPSC-derived CMs provide an un-
limited, autologous cell source that could be utilized for 
therapeutic transplantation as well as drug screening, disease 
modeling, and cardiotoxicity studies. A drawback, however, 
is that current protocols generate iPSC-derived CMs that are 
immature and display characteristics that resemble fetal CMs, 
as demonstrated by a weak force contraction, improper 
electrophysiology, and reduced or absent expression of sev-
eral critical cardiac proteins.10,39 Consequently, there is 
considerable interest in ﬁnding strategies that promote mat-
uration of iPSC-derived CMs. In the current study, we in-
vestigated the properties and composition of native cardiac 
ECM from adult and fetal bovine hearts and tested their 
ability to promote iPSC-derived CM maturation in both 2D 
and 3D conformations. We found several notable differences 
that call into question the continued use of 2D cultures for the 
generation of iPSC-derived CMs, notably that the composi-
tion and stiffness of the 3D matrix convey critical maturation 
signals to the developing CMs. 
Multiple groups have investigated strategies to induce the 
maturation of pluripotent stem cell-derived CMs10–12,14,40–42; 
however, a majority of these studies investigated maturation 
of CMs in 2D. While 2D studies have certainly advanced our 
knowledge of CM maturation, the 3D environment greatly 
impacts cell behavior and maturation,23,43 and so a full un-
derstanding of this process will require the use of a more 
physiologic (3D) environment.44 Previous studies have 
shown that growing pluripotent stem cell-derived CMs in 3D 
beneﬁts maturation induction40–42,45; however, these studies 
used only single-protein ECM scaffolds, which do not reca-
pitulate the complexity of the in vivo ECM. DeQuach et al. 
showed that porcine cardiac ECM affects CM maturation26; 
however, only modest changes were observed, likely due to 
the use of a 2D geometry. 
In the current study, we found that iPSC-derived CMs 
grown in a complex 3D scaffold behave differently to those 
in single protein gels (collagen I or ﬁbrin) and that cells in 
3D differ considerably from those cultured in 2D. This was 
especially notable when we studied calcium handling and 
expression of maturation markers. Although a complete 
mechanistic understanding of how the geometry of the 
cultures impacts cell phenotype is not yet available, we 
hypothesize that biomechanical cues, likely mediated 
through integrins,44,46–48 are critical. 
FIG. 5. 3D adult cardiac ECM increases iPSC-derived CM 
response to drugs. iPSC-derived CMs cultured in 3D were 
more responsive to b-adrenergic stimuli and caffeine than 
cells in 2D cultures. (A) The effect of isoproterenol and 
propranolol on the beat rate of iPSC-derived CMs. (B) A 
representative ﬂuorescent signal of the iPSC-derived CM 
calcium transient in response to 20 mM caffeine cultured in 
2D and 3D adult cardiac ECMs. (C) The time to maximum 
ﬂuorescent output (Fmax) was measured after the addition of 
caffeine. (D) The velocity of calcium release F/time. Results 
are expressed as mean – standard error (n = 13–17; **p < 0.01 
***p < 0.001, Student’s t-test). Color images available online 
at www.liebertpub.com/tea 
The idea of biomechanical cues driving cell maturation is 
supported by our ﬁnding that the fetal and adult cardiac 
ECMs derived from decellularized heart tissue have a sim-
ilar composition, but differ in their mechanical properties 
and ﬁber architecture. The adult ECM has a higher density 
of collagen compared with the fetal ECM, which is similar 
to what has been shown in rat adult cardiac ECM.30 In 
addition, the stiffness of the adult ECM hydrogel is 10-fold 
greater than the fetal hydrogel. These data are in agreement 
with ﬁndings that adult hearts are much stiffer than fetal 
hearts (10–50 KPa vs. 6 KPa),44 and previous studies have 
shown that substrate mechanics, particularly stiffness, in-
ﬂuence CM growth and maturation.44,49 We think it is likely 
that the induction of maturation genes, such as JCN, by  3D  
culture and by the presence of adult versus fetal matrix, is 
largely the result of gel stiffness, which is a consequence of 
gel composition. It is also possible that speciﬁc matrix 
proteins engage with speciﬁc integrins to mediate matura-
tion signals; however, we do not have any data to directly 
support this hypothesis. 
Our investigation into iPSC-derived CM maturation con-
centrated on examining calcium handling. We found that 
iPSC-derived CMs cultured in 3D cardiac ECM showed in-
creased expression of calcium-handling genes compared with 
2D cultures, which is consistent with previous studies that 
primarily focused on the expression of ion channels and con-
tractile machinery.10,11,14 Our data showing an increase in 
calcium-handling genes supports the hypothesis that a 3D 
geometry signiﬁcantly inﬂuences CM maturation. In vivo, 
adult CMs express higher levels of calcium-handling proteins 
than do fetal cells,39 which again is consistent with the idea 
that expression of calcium-handling genes can be used as a 
measure of CM maturity. Interestingly, CMs of the adult heart 
express NCX1 at a lower level than CMs of the fetal heart39; 
however, we see increased NCX1 expression in our 3D cul-
tured CMs, which is similar to results described by Rog-
Zielinska et al.50 We speculate that the 3D cardiac ECM is 
only one component involved in promoting CM maturation 
and that additional maturation stimuli (hormones, growth 
factors, mechanical stretching, signals from non-CM) may 
also affect NCX1 expression. Additionally, CMs cultured in 
3D, compared with 2D, had increased expression of Kir2.1, 
which encodes an inwardly rectifying K+ channel. This was 
recently shown to be the key ion channel that prevents the 
arrhythmias associated with immature CMs.51 Indeed, ex-
pression of Kir2.1 in immature CMs made them electrophys-
iological indistinguishable from mature CMs. Conversely, the 
increase in HCN4 expression in CMs grown in 3D may indi-
cate that our CMs have not yet undergone ventricular CM 
speciﬁcation.52 Furthermore, only a subset of maturation 
genes we studied reached elevated levels indicative of matu-
ration when cells were cultured in 3D gels, which is consistent 
with our CM maturation model being incomplete. 
Consistent with changes in gene expression, we found 
signiﬁcant differences in the calcium handling in CMs, as 
measured by the calcium ﬂux reporter GCaMP6. Recent pub-
lications show that mature CMs display increased calcium sig-
naling and kinetics.10,11 In line with this, we found that in 
aggregates of iPSC-derived CMs, calcium transient amplitude, 
maximum upslope, and maximum downslope were all increased 
and the time to peak and time to 50% and 75% decay were 
correspondingly decreased when cells were in 3D versus 2D. 
These data are entirely consistent with our ﬁndings of increased 
expression of calcium handing genes/proteins such as JCN, 
CASQ2, CaV1.2, Triadin, and SERCA2a in 3D, which would act 
to increase the amount of calcium within the SR and create CMs 
with a greater capacity to handle calcium during calcium-
induced calcium release. Furthermore, numerous publications 
have demonstrated that CMs with increased calcium signaling 
also exhibit functional changes such as increased contractile 
forces and enhanced contractile kinetics.10,11,51,53 
Interestingly, in contrast to this, when we seeded CMs as 
single cells into 3D gels (to allow a more direct comparison of 
matrix effects in 2D vs. 3D) we found that calcium-handling 
kinetics were different—calcium transient amplitude, maxi-
mum upslope, and maximum downslope were all decreased 
and the time to 50% decay was correspondingly increased 
when cells were in 3D versus 2D. This strongly implies that 
gene expression is not enough to determine calcium-handling 
characteristics. Rather, it is the association of cells and the 
coupling of these calcium-handling systems that determines 
the kinetics of calcium handling. Clearly, future studies in 3D 
should focus on aggregated, rather than single, cells. 
In the current study, CMs are cultured for 7 days before 
measuring calcium signaling, similar to Yang et al.11; how-
ever, others have cultured CMs for over 100 days before 
assaying for maturation.10 Interestingly, our unpublished data 
demonstrate that iPSC-derived CMs cultured long term 
(comparing a 5-month with a 2-month culture) exhibit in-
creased calcium signaling and kinetics, suggesting that mat-
uration continues over an extended period of time. 
Additionally, the CM T-tubules were examined and there was 
no apparent difference between the T-tubules of iPSC-derived 
CMs grown in 2D and 3D adult cardiac ECMs (data not 
shown). We speculate that development of mature T-tubules 
may occur over a longer time period than we studied in these 
experiments. Since endogenous CMs take several years before 
maturation is complete, it is not entirely surprising that mat-
uration of CMs in culture may take considerable time. 
An important characteristic of CMs, and one that needs to 
be recapitulated by iPSC-derived CMs, is their response to 
drugs. We found that iPSC-derived CMs cultured in 3D 
were more responsive to various stimuli compared with cells 
cultured in 2D. The addition of the b-adrenergic agonist, 
isoproterenol, to the iPSC-derived CMs cultured in 3D in-
duced an increased beat rate compared with cells in 2D 
culture. Furthermore, exposure to caffeine induced a steeper 
slope and a shorter time to maximum calcium concentration 
in the CMs cultured in the 3D cardiac ECM compared with 
2D. Caffeine is known to increase RyR sensitivity by low-
ering the luminal calcium threshold for calcium release from 
the SR.54 We hypothesize that the 3D culturing of iPSC-
derived CMs increases the slope and decreases the time to 
maximum calcium signaling due to an increase in absolute 
calcium and/or faster release of calcium from the SR caused 
by the increased expression of JCN, CASQ2, and Triadin, 
which are all proteins that handle calcium within the SR and 
modulate its release through the RyR. 
In summary, we have used 3D adult cardiac ECM as a 
strategy to promote iPSC-derived CM maturation. We de-
termined that the age (fetal vs. adult) of the cardiac ECM 
modulates its mechanical properties and ﬁber architecture and 
these aspects affect CM gene and protein expression. After 
7 days of culture within the 3D adult cardiac ECM hydrogels, 
the iPSC-derived CMs showed increased expression of many 
calcium-handling genes, consistent with the increase in these 
genes seen in adult versus fetal CMs. We also report that 
calcium signaling in the iPSC-derived CMs is enhanced in 3D 
compared with 2D, consistent with the changes in gene and 
protein expression. The utilization of 3D adult cardiac ECM 
to culture pluripotent stem cell-derived CMs better recapitu-
lates the in vivo environment than traditional 2D cultures or 
the use of non-native matrix, thereby promoting CM matu-
ration. Our studies help advance strategies for maturing plu-
ripotent stem cell-derived CMs so that they can be safely and 
effectively used for therapeutic applications to treat heart 
disease. 
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